Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARQT | BMY | AMGN | GILD | VRTX |
| Company | Arcutis Biotherapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 11.59 | 67.49 | 233.45 | 79.10 | 303.48 |
| High | 11.59 | 68.00 | 233.95 | 79.38 | 303.99 |
| Low | 10.82 | 67.22 | 229.59 | 77.76 | 297.75 |
| Last | 10.86 | 67.24 | 229.83 | 77.81 | 297.87 |
| Change | -0.70 | -0.27 | -3.12 | -1.33 | -4.79 |
| % Change | -6.06% | -0.40% | -1.34% | -1.68% | -1.58% |
| Volume | 839,200 | 6,657,500 | 1,725,000 | 4,909,500 | 774,600 |
| 20-Day Average Volume | 1,189,590 | 8,463,710 | 2,575,745 | 5,992,210 | 1,047,975 |
| Previous Close | 11.56 | 67.51 | 232.95 | 79.14 | 302.66 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.44 | 68.02 | 232.48 | 79.87 | 292.33 |
| 20-Day Raw Stochastic | 3.04% | 29.31% | 35.55% | 17.54% | 69.99% |
| 20-Day Relative Strength | 27.72% | 39.72% | 40.64% | 38.89% | 51.23% |
| Weighted Alpha | -47.90 | -11.50 | -8.30 | +27.30 | +13.70 |
| Today's Opinion | 100% Sell | 88% Sell | 88% Sell | 8% Sell | 16% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 8% Sell | 32% Buy |
| Last Month's Opinion | 56% Sell | 88% Sell | 56% Sell | 56% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.25% since 03/15/23 | -0.36% since 03/15/23 | -2.16% since 03/15/23 | -2.31% since 03/15/23 | +1.22% since 03/15/23 |
| Low | 10.74 on 03/16/23 | 65.86 on 03/16/23 | 228.52 on 03/17/23 | 76.53 on 03/17/23 | 290.66 on 03/16/23 |
| High | 11.91 on 03/21/23 | 68.00 on 03/22/23 | 235.28 on 03/21/23 | 80.05 on 03/21/23 | 303.99 on 03/22/23 |
| 1-Month | |||||
| %Chg | -31.57% since 02/22/23 | -5.71% since 02/22/23 | -2.68% since 02/22/23 | -6.81% since 02/22/23 | +1.19% since 02/22/23 |
| Low | 10.65 on 03/15/23 | 65.28 on 03/13/23 | 225.40 on 03/09/23 | 76.53 on 03/17/23 | 283.60 on 03/08/23 |
| High | 17.57 on 03/01/23 | 71.98 on 02/23/23 | 237.86 on 02/23/23 | 83.85 on 02/23/23 | 303.99 on 03/22/23 |
| 3-Month | |||||
| %Chg | -23.79% since 12/22/22 | -8.93% since 12/22/22 | -13.36% since 12/22/22 | -8.76% since 12/22/22 | +1.34% since 12/22/22 |
| Low | 10.65 on 03/15/23 | 65.28 on 03/13/23 | 225.40 on 03/09/23 | 76.53 on 03/17/23 | 282.21 on 01/09/23 |
| High | 17.57 on 03/01/23 | 75.18 on 02/06/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 325.19 on 01/31/23 |
| 6-Month | |||||
| %Chg | -41.17% since 09/22/22 | -5.68% since 09/22/22 | +0.91% since 09/22/22 | +22.02% since 09/22/22 | +4.03% since 09/22/22 |
| Low | 10.65 on 03/15/23 | 65.28 on 03/13/23 | 224.56 on 09/23/22 | 61.44 on 10/03/22 | 276.57 on 09/26/22 |
| High | 20.64 on 10/04/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 663,361 | 141,121,696 | 122,723,712 | 97,037,240 | 76,579,696 |
| Shares Outstanding, K | 61,083 | 2,098,776 | 533,976 | 1,247,105 | 257,091 |
| Annual Sales | 3,690,000 | 46,159,000,000 | 26,323,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -311,460,000 | 6,327,000,000 | 6,552,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | 2,960,000 | 11,406,000,000 | 6,839,000,000 | 7,389,000,000 | 2,302,700,000 |
| Last Quarter Net Income | -72,020,000 | 2,022,000,000 | 1,616,000,000 | 1,640,000,000 | 818,900,000 |
| 60-Month Beta | 0.52 | 0.46 | 0.65 | 0.38 | 0.49 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.18 on 02/28/23 | 1.82 on 02/02/23 | 4.09 on 01/31/23 | 1.67 on 02/02/23 | 3.76 on 02/07/23 |
| Latest Earnings Date | 05/04/23 | 04/27/23 | 04/26/23 | 04/27/23 | 05/04/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 2.130 on 02/14/23 | 0.750 on 03/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 04/06/23 | 05/17/23 | 03/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 8.77 | 13.17 | 10.89 | 22.65 |
